AN2 Therapeutics, Inc. - Common Stock (ANTX)

AN2 Therapeutics, Inc. is a biopharmaceutical company focused on developing innovative therapies for the treatment of infectious diseases, particularly those caused by viruses

The company is dedicated to advancing its pipeline of novel antiviral therapies, leveraging cutting-edge research to address urgent medical needs. With a commitment to improving patient outcomes, AN2 employs a science-driven approach to create effective and accessible treatment options, ultimately aiming to contribute to global public health efforts. Through rigorous clinical development and collaboration with healthcare professionals, the company strives to bring transformative solutions to patients suffering from serious infectious diseases.